Daptomycin 350 Mg In 7 Ml Breastfeeding

Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Daptomycin 350 Mg In 7 Ml while breastfeeding. We will also discuss about common side effects and warnings associated with Daptomycin 350 Mg In 7 Ml.

What is Daptomycin 350 Mg In 7 Ml used for?


Daptomycin for Injection is a lipopeptide antibacterial indicated for the treatment of: Complicated skin and skin structure infections (cSSSI) in adult patients ( 1.1) and, Staphylococcus aureus bloodstream infections (bacteremia), in adult patients including those with right-sided infective endocarditis, ( 1.2) Limitations of Use: Daptomycin for Injection is not indicated for the treatment of pneumonia. ( 1.3) Daptomycin for Injection is not indicated for the treatment of left-sided infective endocarditis due to S. aureus. ( 1.3) To reduce the development of drug-resistant bacteria and maintain the effectiveness of Daptomycin for Injection and other antibacterial drugs, Daptomycin for Injection should be used to treat infections that are proven or strongly suspected to be caused by bacteria. ( 1.4) 1.1 Complicated Skin and Skin Structure Infections (cSSSI) Daptomycin for Injection is indicated for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible isolates of the following Gram-positive bacteria: Staphylococcus aureus (including methicillin-resistant isolates), Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae subsp. equisimilis, and Enterococcus faecalis (vancomycin-susceptible isolates only). Pediatric use information is approved for Merck & Co., Inc.’s Cubicin (daptomycin for injection). However, due to Merck & Co., Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. 1.2 Staphylococcus aureus Bloodstream Infections (Bacteremia) in Adult Patients, Including Those with Right-Sided Infective Endocarditis, Caused by Methicillin-Susceptible and Methicillin-Resistant Isolates Daptomycin for Injection is indicated for the treatment of adult patients with Staphylococcus aureus bloodstream infections (bacteremia), including adult patients with right-sided infective endocarditis, caused by methicillin-susceptible and methicillin-resistant isolates. Pediatric use information is approved for Merck & Co., Inc.’s Cubicin (daptomycin for injection). However, due to Merck & Co., Inc.’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. 1.3 Limitations of Use Daptomycin for Injection is not indicated for the treatment of pneumonia. Daptomycin for Injection is not indicated for the treatment of left-sided infective endocarditis due to S. aureus. The clinical trial of Daptomycin for Injection in adult patients with S. aureus bloodstream infections included limited data from patients with left-sided infective endocarditis; outcomes in these patients were poor [see Clinical Studies ( 14.2)] . Daptomycin for Injection has not been studied in patients with prosthetic valve endocarditis. 1.4 Usage Appropriate specimens for microbiological examination should be obtained in order to isolate and identify the causative pathogens and to determine their susceptibility to daptomycin. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Daptomycin for Injection and other antibacterial drugs, Daptomycin for Injection should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information is available, it should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Empiric therapy may be initiated while awaiting test results.

I am breastfeeding mother and I am using Daptomycin 350 Mg In 7 Ml. Can it have any bad effect on my kid? Shall I search for better alternative?

Daptomycin 350 Mg In 7 Ml contains Daptomycin as active ingredients, . We do not have safety rating of Daptomycin but we do have analysis of Daptomycin, which is used in manufacturing of Daptomycin 350 Mg In 7 Ml. You can get a good idea about Daptomycin 350 Mg In 7 Ml usage while breastfeeding by going through our detailed analysis as below.

Daptomycin 350 Mg In 7 Ml Breastfeeding Analsys


Daptomycin while Breastfeeding

CAS Number: 103060-53-3

Limited and somewhat inconsistent information indicates that daptomycin produces very low levels in milk and it would not be expected to cause any adverse effects in breastfed infants. No special precautions are required.


Daptomycin 350 Mg In 7 Ml and breastfeeding

What should I do if already breastfed my kid after using Daptomycin 350 Mg In 7 Ml?

We are not completely sure about safety of Daptomycin 350 Mg In 7 Ml in breastfeeding. We would suggest you to contact your doctor or health care provider and explain your situation with Daptomycin 350 Mg In 7 Ml. If you observe anything abnormal with your baby please call 911 or contact emergency services in your area.


I am nursing mother and my doctor has suggested me to use Daptomycin 350 Mg In 7 Ml, is it safe?

If your doctor considers Daptomycin 350 Mg In 7 Ml safe enough to prescribe for you that means its benefits outweigh its known risks.


If I am using Daptomycin 350 Mg In 7 Ml, will my baby need extra monitoring?

Not Sure, Please check with your doctor or lactation consultant.


Who can I talk to if I have questions about usage of Daptomycin 350 Mg In 7 Ml in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week